Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 5
2005 3
2006 4
2007 2
2008 3
2009 4
2010 3
2011 8
2012 5
2013 7
2014 7
2015 8
2016 8
2017 11
2018 13
2019 10
2020 11
2021 13
2022 10
2023 6
2024 6
2025 12
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Nebulised hypertonic saline solution for acute bronchiolitis in infants.
Zhang L, Mendoza-Sassi RA, Wainwright CE, Aregbesola A, Klassen TP. Zhang L, et al. Among authors: wainwright ce. Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD006458. doi: 10.1002/14651858.CD006458.pub5. Cochrane Database Syst Rev. 2023. PMID: 37014057 Free PMC article. Review.
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS; VX08-770-102 Study Group. Ramsey BW, et al. Among authors: wainwright ce. N Engl J Med. 2011 Nov 3;365(18):1663-72. doi: 10.1056/NEJMoa1105185. N Engl J Med. 2011. PMID: 22047557 Free PMC article. Clinical Trial.
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
Zemanick ET, Taylor-Cousar JL, Davies J, Gibson RL, Mall MA, McKone EF, McNally P, Ramsey BW, Rayment JH, Rowe SM, Tullis E, Ahluwalia N, Chu C, Ho T, Moskowitz SM, Noel S, Tian S, Waltz D, Weinstock TG, Xuan F, Wainwright CE, McColley SA. Zemanick ET, et al. Among authors: wainwright ce. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC. Am J Respir Crit Care Med. 2021. PMID: 33734030 Free PMC article. Clinical Trial.
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.
Mall MA, Brugha R, Gartner S, Legg J, Moeller A, Mondejar-Lopez P, Prais D, Pressler T, Ratjen F, Reix P, Robinson PD, Selvadurai H, Stehling F, Ahluwalia N, Arteaga-Solis E, Bruinsma BG, Jennings M, Moskowitz SM, Noel S, Tian S, Weinstock TG, Wu P, Wainwright CE, Davies JC. Mall MA, et al. Among authors: wainwright ce. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1361-1369. doi: 10.1164/rccm.202202-0392OC. Am J Respir Crit Care Med. 2022. PMID: 35816621 Free PMC article. Clinical Trial.
Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking Water.
Thomson RM, Wheeler N, Stockwell RE, Bryant J, Taylor SL, Leong LEX, Le T, Rogers GB, Carter R, Sherrard LJ, Powell H, Simpson G, Patterson-Fahy K, Wainwright CE, Floto RA, Parkhill J, Bell SC. Thomson RM, et al. Among authors: wainwright ce. Am J Respir Crit Care Med. 2025 May;211(5):842-853. doi: 10.1164/rccm.202409-1824OC. Am J Respir Crit Care Med. 2025. PMID: 40072241
Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study.
Mall MA, Wainwright CE, Legg J, Chilvers M, Gartner S, Dittrich AM, Stehling F, Conner S, Grant S, Suresh N, Weinstock TG, Davies JC; VX20-445-119 Study Group. Mall MA, et al. Among authors: wainwright ce. Eur Respir J. 2025 Jul 14;66(1):2402435. doi: 10.1183/13993003.02435-2024. Print 2025 Jul. Eur Respir J. 2025. PMID: 40210412 Free PMC article. Clinical Trial.
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium.
O'Donnell JEM, Hastings LA, Briody JN, Chan CL, Colombo C, Douglas TA, Freedman SD, Gonska T, Greenfield JR, Leung DH, Lim AYL, Moran A, Prentice BJ, Putman MS, Trotter M, Tullis E, Westall GP, Verge CF, Wainwright CE, Ooi CY; SHIFT Symposium 2021. O'Donnell JEM, et al. Among authors: wainwright ce. Pediatr Pulmonol. 2024 Jun;59(6):1661-1676. doi: 10.1002/ppul.26970. Epub 2024 Apr 12. Pediatr Pulmonol. 2024. PMID: 39903130
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis.
Lynch M, Manoy S, Sly PD, Wainwright CE, Wolvetang E, Feenstra JE, Dowling J, Ware RS, Patel MS, Hermith-Ramirez D, Vogel A, Preece K, Zappala T, Dai S, Webber A, Yeo A, Subramanian G, Rao G, Ma CS, Jose S, Gatei M, Xin B, Sandona N, Lewindon P, Sinclair KG, Nayler S, Lavin MF, Coman DJ. Lynch M, et al. Among authors: wainwright ce. EBioMedicine. 2025 Aug;118:105840. doi: 10.1016/j.ebiom.2025.105840. Epub 2025 Jul 4. EBioMedicine. 2025. PMID: 40616902 Free PMC article. Clinical Trial.
139 results